A trial of inhaled heparin in patients with acute lung injury

A phase 2 randomised blinded trial of nebulised heparin in patients requiring mechanical ventilation for more than 48 hours

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12608000121369

Enrollment

Registered

2008-03-05

Start date

2008-04-04

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To investigate if nebulised heparin improves oxygenation of patients with acute lung injury

Interventions

Inhaled heparin (5 ml) will be given daily for 14 days or until extubation

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Healthy volunteers

Inclusion criteria

Has or at high risk of developing acute lung injury

Exclusion criteria

At risk of pulmonary hemorrhage Allergy to heparin

Outcome results